About this Research Topic
This Research Topic in Antimicrobial Resistance (AMR) will focus on the relationship between vaccines and AMR-sensitive or AMR-related disease incidence as well as health outcomes, in human and animal populations.
The impact of vaccinations in preventing and controlling AMR in illness due to vaccine-preventable priority pathogens is direct and clear; however, questions remain as to the indirect impact of the use of viral vaccines in preventing AMR. Analyzing the role of these vaccines as well as animal vaccines in the OneHealth models can further project the shared benefits of vaccines as AMR prevention tools. Manuscripts in this collection should address the following:
1. The global and regional burden of AMR in GLASS priority pathogens (pneumococcus, typhoidal and non typhoidal salmonellae, Haemophilus) that cause vaccine preventable illness, and the efficacy of vaccines in reducing AMR in these pathogens.
2. Reviews and original research (including protocols) on vaccines in development with the potential to address AMR in other priority pathogens and strategies for evaluation and implementation.
3. Economic impact of the use of vaccines and AMR related socioeconomic and health outcomes.
4. Immunomodulatory and microbiome/resistome-modulatory impact of vaccines and putative impact on AMR prevention.
Keywords: antimicrobial resistance, AMR, vaccinations, vaccine development, OneHealth
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.